0001437749-21-006473.txt : 20210319 0001437749-21-006473.hdr.sgml : 20210319 20210319170434 ACCESSION NUMBER: 0001437749-21-006473 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210316 FILED AS OF DATE: 20210318 DATE AS OF CHANGE: 20210319 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tucker Sean CENTRAL INDEX KEY: 0001652204 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35285 FILM NUMBER: 21758978 MAIL ADDRESS: STREET 1: 385 OYSTER POINT BLVD., SUITE 9A CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vaxart, Inc. CENTRAL INDEX KEY: 0000072444 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 591212264 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 385 OYSTER POINT BOULEVARD, SUITE 9A CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 550-3500 MAIL ADDRESS: STREET 1: 385 OYSTER POINT BOULEVARD, SUITE 9A CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: Aviragen Therapeutics, Inc. DATE OF NAME CHANGE: 20160413 FORMER COMPANY: FORMER CONFORMED NAME: Biota Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20121113 FORMER COMPANY: FORMER CONFORMED NAME: NABI BIOPHARMACEUTICALS DATE OF NAME CHANGE: 20100719 4 1 rdgdoc.xml FORM 4 TUCKER X0306 4 2021-03-16 0000072444 Vaxart, Inc. VXRT 0001652204 Tucker Sean C/O VAXART, INC. 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 1 Chief Scientific Officer Common Stock 2021-03-16 4 M 0 1006 6.49 A 48053 D Common Stock 57293 I By joint tenancy with Frances Chang and Sean Tucker Common Stock 9060 I By spouse Stock Option (right to buy) 6.49 2021-03-16 4 M 0 1006 0 D 2021-03-29 Common stock 1006 0 D The option is fully vested /s/ Sean N. Tucker 2021-03-18